Oct 1, 2024 | 2024, Investors, Press Releases
more detailsOct 1, 2024 | 2024, Investors, Press Releases
more detailsSep 27, 2024 | 2024, Events, Scientific
Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”. Dr. Sebastian Oehler...Sep 25, 2024 | 2024, Investors, Press Releases
more detailsSep 25, 2024 | 2024, Investors, Press Releases
more details
Recent Comments